Nutriband

Yahoo Finance • 8 days ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™... Full story

Yahoo Finance • 14 days ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it received a Notice of Allowance... Full story

Yahoo Finance • 2 years ago

Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV

LAS VEGAS, NV / ACCESSWIRE / April 24, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino... Full story

Yahoo Finance • 2 years ago

Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development

ORLANDO, FL / ACCESSWIRE / April 4, 2023 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) with Kindeva Drug Delivery ("Kindeva") have selected the target AVERSA™ formulation to take forward into commercial scale manufacturing proces... Full story

Yahoo Finance • 2 years ago

Nutriband Approved for Dual Listing on Upstream

Trading to Commence on Upstream January 5, 2023 under Upstream Ticker Symbol NTRB; all Upstream Participants Eligible to Receive Commemorative NFT ORLANDO, FL / ACCESSWIRE / December 14, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) t... Full story